Connection

MOHIT HULSURKAR to Xenograft Model Antitumor Assays

This is a "connection" page, showing publications MOHIT HULSURKAR has written about Xenograft Model Antitumor Assays.
  1. CKB inhibits epithelial-mesenchymal transition and prostate cancer progression by sequestering and inhibiting AKT activation. Neoplasia. 2021 11; 23(11):1147-1165.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.